OrbiMed Advisors »

United Therapeutics Corporation shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2011-12-31 $9.3M 198k 47.25
2011-06-30 $3.5M 63k 55.10
2011-03-31 $5.9M 89k 67.02
2010-12-31 $2.0M 31k 63.23

More positions owned by OrbiMed Advisors

Sinovac Biotech SHS (SVA)
Eli Lilly & Co. (LLY)
Edgewise Therapeutics (EWTX)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Biogen Idec (BIIB)
Merck & Co (MRK)
Janux Therapeutics (JANX)
Enliven Therapeutics (ELVN)
Tenet Healthcare Corp Com New (THC)
BioMarin Pharmaceutical (BMRN)
Alpine Immune Sciences (ALPN)
Disc Medicine (IRON)
Stryker Corporation (SYK)
Silverback Therapeutics (SPRY)

View all positions for OrbiMed Advisors

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
FMR
AQR Capital Management
Geode Capital Management
Citadel Advisors
Citigroup
Henderson Group
Hanna Zanoni
Dimensional Fund Advisors
Morgan Stanley
LSV Asset Management
Pacer Advisors

View all funds holding United Therapeutics Corporation